Q2 2016 Holdings
Filed 2016-08-15 | 39 holdings | $1.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $1.0M | 76,511 | 72.9% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $31.9K | 2,109,099 | 2.3% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $30.3K | 2,705,758 | 2.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $30.0K | 3,444 | 2.2% |
| Synergy Pharmaceuticals del | COM NEW | 871639308 | $28.8K | 7,590,000 | 2.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $25.0K | 3,200,000 | 1.8% |
| Dermira Inc(DERMEUR) | COM | 24983L104 | $23.4K | 800,000 | 1.7% |
| Bluebird BIO Inc | COM | 09609G100 | $21.6K | 500,000 | 1.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $21.4K | 470,000 | 1.5% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $21.3K | 548,290 | 1.5% |
| Zogenix Inc | COM NEW | 98978L204 | $19.7K | 2,440,959 | 1.4% |
| Ignyta Inc | COM | 451731103 | $17.6K | 3,238,703 | 1.3% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $11.9K | 538,024 | 0.9% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $9.9K | 330,000 | 0.7% |
| Tetraphase Pharmaceuticals I | COM | 88165N105 | $9.9K | 2,299,529 | 0.7% |
| Connecture Inc | COM | 20786J106 | $9.3K | 4,127,232 | 0.7% |
| Xencor Inc(XNCR) | COM | 98401F105 | $8.5K | 450,000 | 0.6% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $7.2K | 2,457,144 | 0.5% |
| Alcobra LTD | SHS | M2239P109 | $6.4K | 1,414,573 | 0.5% |
| Raptor Pharmaceutical Corp | COM | 75382F106 | $5.3K | 978,350 | 0.4% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $4.6K | 238,900 | 0.3% |
| Sunesis Pharmaceuticals Inc | COM NEW | 867328601 | $4.5K | 8,173,937 | 0.3% |
| Bovie Medical Corp | COM | 10211F100 | $4.4K | 2,680,000 | 0.3% |
| Aradigm Corp(ARDMEUR) | COM NO PAR NEW | 038505400 | $4.4K | 1,002,962 | 0.3% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.9K | 100,000 | 0.3% |
| Ocera Therapeutics Inc | COM | 67552A108 | $3.7K | 1,963,777 | 0.3% |
| Seres Therapeutics Inc(MCRB1EUR)Put | PUT | 81750R102 | $3.5K | 120,000 | 0.3% |
| Tenax Therapeutics Inc | COM | 88032L100 | $2.8K | 1,108,593 | 0.2% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $1.7K | 274,756 | 0.1% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $1.7K | 550,116 | 0.1% |
| Caladrius Biosciences Inc | COM | 128058104 | $900 | 1,525,244 | 0.1% |
| Dipexium Pharmaceuticals Inc | COM | 25456J104 | $871 | 87,914 | 0.1% |
| Vericel Corp(VCEL) | COM | 92346J108 | $570 | 253,502 | 0.0% |
| Paratek Pharmaceuticals Inc | COM | 699374302 | $407 | 29,266 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $321 | 25,000 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $295 | 21,665 | 0.0% |
| Streamline Health Solutions | COM | 86323X106 | $182 | 151,611 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $112 | 50,000 | 0.0% |
| Amarin Corp PLC | SPON ADR NEW | 023111206 | $4 | 2,000 | 0.0% |